Jaya Ganesh is a Rare/Genetic physician affiliated with Mount Sinai Medical Center. OpenAlex indexes 119 publications with 2,662 citations (h-index 22).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Genetics & Genomic Sciences
1 Gustave Levy L. Place #1497
New York, NY 100296500
Telephone
212-241-6947Registry record last updated 25 Mar 2019.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year20254 payments
- UCB, Inc.Program year20251 payment
- GENZYME CORPORATIONProgram year20249 payments$10,056openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
100%Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme57.4%Fabrazyme100%Part D<11 patientsVarious alimentary tract and metabolism products31.2%Ravicti66%Galafold34%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Long‐Term Efficacy and Tolerability of Pegzilarginase in Arginase 1 Deficiency: Results of Two International Multicentre Open‐Label Extension Studies
Journal of Inherited Metabolic Disease
2025 - Long‐Term Safety and Clinical Outcomes With Olipudase Alfa Enzyme Replacement Therapy in Children and Adolescents With Acid Sphingomyelinase Deficiency
Journal of Inherited Metabolic Disease
2025 - Isaralgagene civaparvovec (ST-920) gene therapy in adults with Fabry disease: Updated results from an ongoing phase 1/2 study (STAAR)
Molecular Genetics and Metabolism
2025 - A Case of DNAJC12-Deficient Hyperphenylalaninemia Detected on Newborn Screening: Clinical Outcomes from Early Detection
International Journal of Neonatal Screening
2024 - Isaralgagene civaparvovec (ST-920) gene therapy in adults with Fabry disease: Updated results from an ongoing phase 1/2 study (STAAR)
Molecular Genetics and Metabolism
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Edward Wolin, MD
Mount Sinai Medical Center
David Nierman, MD
Mount Sinai Medical Center
Efsevia Albanis, MD
Mount Sinai Medical Center
Fenella Greig, MD
Mount Sinai Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”